{
  "data": [
    {
      "question": "What is the empirical formula and molecular weight of the compound used in the single crystal x-ray diffraction study identified as vL301SF_0m?",
      "answer": "The empirical formula is C30.84 H37.31 Au B22 Br12 Cl0.47 F0.77 N2 S and the molecular weight is 1892.89.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "What are the crystal system and space group for the compound with the identification code vl358vl?",
      "answer": "The crystal system is Triclinic and the space group is P-1 for the compound with the identification code vl358vl.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "For the compound 10Br12[Ir+], what are the final R indices for data greater than 2sigma(I)?",
      "answer": "For the compound 10Br12[Ir+], the final R indices for data greater than 2sigma(I) are R1 = 0.0239 and wR2 = 0.0494.",
      "difficulty": "hard",
      "type": "factual"
    },
    {
      "question": "What is the method used for absorption correction in the crystal structure determination of 11Br12[Ph3C+]?",
      "answer": "The method used for absorption correction in the crystal structure determination of 11Br12[Ph3C+] is semi-empirical from equivalents.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "What are the theta range for data collection and the density (calculated) for the compound with the identification code vl358vl?",
      "answer": "For the compound with the identification code vl358vl, the theta range for data collection is 1.876 to 29.130Â° and the calculated density is 2.507 Mg/m3.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "How was the disorder in the cyclooctadiene ligand on the cationic iridium moiety of the compound vl338vl addressed during refinement?",
      "answer": "The disorder in the cyclooctadiene ligand on the cationic iridium moiety of the compound vl338vl was addressed during refinement by modeling it over two positions with the help of similarity restraints on 1,2- and 1,3- distances as well as similarity and rigid-bond restraints on anisotropic displacement parameters.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "What was the yield and the method used to synthesize 14Br12[Li+] starting from 14Br12[Me3NH+]?",
      "answer": "The yield of 14Br12[Li+] synthesized from 14Br12[Me3NH+] was 89%, and the method involved reacting 14Br12[Me3NH+] with lithium hydride in tetrahydrofuran, followed by concentration and addition to hexanes to precipitate the product.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "Is the compound 11I12[CPh3+] soluble in any solvent as per the synthesis description provided?",
      "answer": "No, the compound 11I12[CPh3+] is not soluble in any solvent as per the synthesis description provided, which complicates its synthesis from the silver salt 9I12[Ag+].",
      "difficulty": "medium",
      "type": "True or False"
    },
    {
      "question": "Was the cyclization of the diimine to its corresponding imidazolium for compounds 14Br12[Li+] and 14I12[Li+] high yielding?",
      "answer": "No, the cyclization of the diimine to its corresponding imidazolium for compounds 14Br12[Li+] and 14I12[Li+] was extremely low yielding, with yields less than 10%.",
      "difficulty": "medium",
      "type": "True or False"
    },
    {
      "question": "Does the crystal structure determination of 11Br12[Ph3C+] indicate the presence of any solvent molecules in the asymmetric unit?",
      "answer": "Yes, the crystal structure determination of 11Br12[Ph3C+] indicates the presence of one partially occupied disordered C6H5F and one partially occupied CH2Cl2 solvent molecule in the asymmetric unit.",
      "difficulty": "medium",
      "type": "True or False"
    }
  ]
}
